Paper30712434
Evaluation of topical econazole nitrate formulations with potential for treating Raynaud's phenomenon.
Bahl D and 5 others. Pharm Dev Technol, 2019. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Evaluation of topical econazole nitrate formulations with potential for treating Raynaud's phenomenon. Papers, record 30712434. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30712434
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Evaluation of topical econazole nitrate formulations with potential for treating Raynaud's phenomenon.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 14-alpha Demethylase Inhibitors | Major topic |
| Antifungal Agents | Major topic |
| Econazole | Major topic |
| Pharmaceutical Vehicles | Major topic |
| Raynaud Disease | Major topic |
| Administration, Topical | |
| Animals | |
| Crystallization | |
| Drug Compounding | |
| Humans | |
| Hypromellose Derivatives | |
| Skin Absorption | |
| Swine |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41012517 | Evaluation of Permeation Enhancers for Vaginal Delivery of Buserelin Acetate Using a Validated Chromatographic Method and Ex Vivo Porcine Model. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012517 | PubMed |
| 40430887 | Preparation and Evaluation of Tadalafil-Loaded Nanoemulgel for Transdermal Delivery in Cold-Induced Vasoconstriction: A Potential Therapy for Raynaud's Phenomenon. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40430887 | PubMed |
| 38005174 | Drug-Eluting Sutures by Hot-Melt Extrusion: Current Trends and Future Potentials. | Materials (Basel) | 2023 | https://conductscience.org/library/papers/38005174 | PubMed |
| 37446893 | Fabrication, Characterization and Biomedical Evaluation of a Statistically Optimized Gelatin Scaffold Enriched with Co-Drugs Loaded into Controlled-Release Silica Nanoparticles. | Molecules | 2023 | https://conductscience.org/library/papers/37446893 | PubMed |
| 35976012 | Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands. | Med Res Rev | 2022 | https://conductscience.org/library/papers/35976012 | PubMed |
| 32070011 | Alternatives to Biological Skin in Permeation Studies: Current Trends and Possibilities. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32070011 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30712434
GET https://conductscience.org/api/papers/v1/30712434/authors